The Lancet (British edition), 2022-11, Vol.400 (10364), p.1661-1663
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- The polypill: from concept and evidence to implementation
- Ist Teil von
- The Lancet (British edition), 2022-11, Vol.400 (10364), p.1661-1663
- Ort / Verlag
- London: Elsevier Ltd
- Erscheinungsjahr
- 2022
- Quelle
- Elsevier ScienceDirect Journals Complete
- Beschreibungen/Notizen
- [...]a strategy focused solely on secondary prevention would not address 80% of the cardiovascular disease burden. [...]polypills are not included in current guidelines for cardiovascular disease prevention or in the WHO's Essential Medicines List. [...]companies should develop newer polypills with larger blood-pressure-lowering effects (eg, by combining low doses of three or four classes of blood-pressure-lowering drugs along with statins and low doses of aspirin), which could result in greater clinical benefits.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0140-6736eISSN: 1474-547XDOI: 10.1016/S0140-6736(22)01847-5Titel-ID: cdi_proquest_miscellaneous_2725190811